neostigmine has been researched along with Dermatomyositis, Adult Type in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vasilescu, C | 1 |
| Bucur, G | 1 |
| Petrovici, A | 1 |
| Florescu, A | 1 |
| Mittelbach, F | 1 |
| Bodechtel, G | 1 |
2 other studies available for neostigmine and Dermatomyositis, Adult Type
| Article | Year |
|---|---|
Myasthenia in patients with dermatomyositis: clinical, electrophysiological and ultrastructural studies.
Topics: Adolescent; Adult; Biopsy; Dermatomyositis; Electromyography; Evoked Potentials; Fatigue; Female; Gl | 1978 |
[On the therapy of muscular diseases].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Cholinesterase Inhibitors; Dermatomyositis; Humans; Immuno | 1968 |